Corporate Statement

Mallinckrodt Pharmaceuticals is a multibillion dollar specialty pharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to address unmet patient needs, stemming from 150 years of using our unique strengths, experience and expertise to help improve people’s lives. Discover how our rich history of innovation and patient-centered solutions has helped influence our vision for the future.

Stock Information

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Investor Overview

News Releases

17 May '22
Retrospective medical chart review subgroup analysis showed Acthar Gel was associated with overall symptom improvement and reduction in use of concomitant medications in African Americans DUBLIN  , May 17, 2022 /PRNewswire/ -- Mallinckrodt plc , (OTCMKTS: MNKKQ) a global biopharmaceutical company,

Recent Events

Featured Reports

go back to the top of the page